selenocysteine has been researched along with Animal Mammary Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlson, BA; Green, JE; Hatfield, DL; Hoeneroff, MJ; Hudson, TS; Muller, WJ; Sordillo, L; Young, HA | 1 |
| Koul, D; Sinha, R; Unni, E; Yung, WK | 1 |
| Medina, D; Said, TK; Sinha, R | 1 |
3 other study(ies) available for selenocysteine and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Disease Progression; Female; Genotype; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Mice; Mice, Inbred C57BL; Mice, Knockout; RNA, Transfer, Amino Acid-Specific; Selenocysteine; Selenoproteins | 2012 |
Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro.
Topics: Animals; Anticarcinogenic Agents; Cell Division; Cell Line, Tumor; Cysteine; Enzyme Inhibitors; Epithelial Cells; Mammary Neoplasms, Animal; MAP Kinase Signaling System; Mice; Organoselenium Compounds; p38 Mitogen-Activated Protein Kinases; Phosphoinositide-3 Kinase Inhibitors; Selenocysteine | 2005 |
Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways.
Topics: Animals; Antineoplastic Agents; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Drug Screening Assays, Antitumor; Female; Mammary Neoplasms, Animal; Mice; Protein Serine-Threonine Kinases; Selenocysteine; Sodium Selenite; Tumor Cells, Cultured | 1996 |